Flemming_Ørnskov

Flemming Ørnskov

Flemming Ørnskov

Danish pharmaceutical executive

Flemming Ørnskov (born 1957/58) is a Danish businessman. He has been the chief executive officer (CEO) of Galderma[2] since October 2019.

Quick Facts Born, Nationality ...

He was previously the CEO of Shire plc, a FTSE 100 specialty biopharmaceutical company as of 30 April 2013, succeeding Angus Russel.[3] He previously worked for Bayer, Bausch & Lomb and Novartis.[2]

He is also the chairman of Waters Corporation.[4]

Ørnskov received his MD from the University of Copenhagen, followed by an MBA from INSEAD, and a Master of Public Health (MPH) from Harvard University.[1]

Awards

Top 100 Best-Performing CEOs in the World, 2015 - Harvard Business Review[5]

Top 25 Most Influential People in Biopharma Today, 2013 - Fierce Biotech[6]

References

  1. [1]
    "Executive Profile: Flemming Ornskov". Bloomberg. Retrieved 4 September 2017.
  2. [2]
    Liu, Angus (October 8, 2019). "Ex-Shire CEO Flemming Ornskov emerges as Galderma CEO after $10B Nestlé spinout". Fiercepharma.
  3. [3]
    "Shire chief finds right prescription for growth". The Telegraph. Retrieved 20 March 2014.
  4. [4]
    "Conseil d'administration : Waters". www.waters.com. Retrieved 2021-04-01.
  5. [5]
    "The 'best-performing' CEO in the world is a pharma chief". BioPharma Dive. Retrieved 2021-04-01.
  6. [6]
    "The 25 most influential people in biopharma today - 2013". FierceBiotech. Retrieved 2021-04-01.


Flag of DenmarkBiography icon

This Danish biographical article is a stub. You can help Wikipedia by expanding it.

Stub icon

This business-related biographical article is a stub. You can help Wikipedia by expanding it.
Share this article:

This article uses material from the Wikipedia article Flemming_Ørnskov, and is written by contributors. Text is available under a CC BY-SA 4.0 International License; additional terms may apply. Images, videos and audio are available under their respective licenses.